Clinical trial
Intravesical Mistletoe Extract in Superficial Bladder Cancer: A Phase III Efficacy Study
NCT02106572 is registered in ClinicalTrials.gov with Abnoba Gmbh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intravesical Mistletoe Extract in Superficial Bladder Cancer: A Phase III Efficacy Study
- Lead sponsor
- Abnoba Gmbh
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- April 30, 2015
- Completion date
- April 24, 2026
- Enrollment
- 174 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
superficial bladder cancer